© Copyright 2025 American Medical Association. All rights reserved.
A live attenuated human rotavirus vaccine, designated as RV1, is administered orally in a two-dose schedule. This vaccine is specifically designed to provide long-term immunity against rotavirus, a highly contagious virus that is a leading cause of severe gastroenteritis in infants and young children. Unlike immune globulins, which offer only short-term, passive immunity, vaccines like RV1 stimulate the recipient's immune system to produce its own antibodies. This process involves exposing the immune system to a modified version of the virus, which helps the body learn to recognize and combat the actual virus in the future. Rotavirus infection is prevalent, with nearly every child in the United States experiencing it by the age of five, often resulting in multiple episodes of vomiting and severe diarrhea that may necessitate hospitalization. The RV1 vaccine contains a weakened strain of the rotavirus, ensuring safety while effectively preparing the immune system to respond to future infections. It is important to note that this CPT® code specifically reports the supply of the vaccine and does not include the oral administration of the vaccine itself.
© Copyright 2025 Coding Ahead. All rights reserved.
The rotavirus vaccine (RV1) is indicated for the prevention of rotavirus disease in infants and young children. The following conditions highlight the necessity of this vaccination:
The administration of the rotavirus vaccine (RV1) follows a structured procedure to ensure proper immunization. The steps involved are as follows:
Following the administration of the rotavirus vaccine, it is important to provide appropriate post-procedure care. Parents or guardians should be informed about potential mild side effects, which may include irritability, mild diarrhea, or vomiting. These symptoms are generally short-lived and resolve without intervention. It is also essential to advise caregivers to monitor the child for any unusual reactions and to contact a healthcare provider if severe symptoms occur. The child should continue to receive routine pediatric care and follow-up vaccinations as per the recommended immunization schedule.
Short Descr | RV1 VACC 2 DOSE LIVE ORAL | Medium Descr | RV1 VACCINE 2 DOSE SCHEDULE LIVE FOR ORAL USE | Long Descr | Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use | Status Code | Excluded from Physician Fee Schedule by Regulation | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Not Billable to the MAC | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | O1G - Immunizations/Vaccinations | MUE | 1 | CCS Clinical Classification | 228 - Prophylactic vaccinations and inoculations |
Date
|
Action
|
Notes
|
---|---|---|
2016-01-01 | Changed | First appearance of change in codebook. |
2015-07-01 | Changed | Description Changed |
2009-01-01 | Added | First appearance in code book in 2009. |
2008-01-01 | Added | - |
Get instant expert-level medical coding assistance.